Section 693.140  Control Measures

a)         The STDs designated pursuant to this Part have the following incubation periods:

1)         Syphilis:  10 to 90 days, usually 21 days;

2)         Gonorrhea:  Usually 2 to 15 days, sometimes 30 days longer;

3)         Chlamydia:  Unknown;

4)         AIDS:  Unknown -- may be several months to several years;

5)         HIV infection:  Seroconversion usually occurs several weeks to six months after infection, sometimes one year or longer;

6)         Chancroid: 3 to 5 days, may be up to 14 days;

7)         Ophthalmia Neonatorum: usually 36 to 48 hours.

b)         Disinfection

1)         AIDS/HIV:  Concurrent disinfection is required of equipment contaminated by blood, secretions and excretions;

2)         Syphilitic infants:  Cases with florid eruptions are infectious and appropriate precautions and disinfection procedures are required in accordance with CDC Guidelines for Isolation Precautions in Hospitals (See 77 Ill. Adm. Code 690.1000 (d)(1));

3)         Other STDs:  Concurrent disinfection of abnormal discharges and secretions is required;

4)         "Disinfection" means the inactivation of potentially harmful microorganisms;

5)         Ophthalmia Neonatorum (Gonococcal):

A)        Isolation is required for the first 24 hours after administration of antibiotic;

B)        Concurrent disinfection is accomplished by care in disposal of conjunctival discharges and articles soiled therewith;

C)        Terminal cleaning is required.

c)         Special precautions for AIDS and HIV infection

1)         Health care personnel and others who provide direct patient care providing care to persons with AIDS or HIV infection in facilities such as hospitals, nursing homes, alcoholism treatment or mental health facilities, through outpatient or home health services, shall observe those protective measures as described in the publication "Recommendations for Prevention of HIV Transmission in Health-Care Settings" (Centers for Disease Control and Prevention, MMWR 1987, vol. 36, Suppl. no. 25, pages 3S-18S) and the "Joint Advisory Notice, Department of Labor/Department of Health and Human Services, HBV/HIV" Federal Register, Vol. 52, No. 210, pp. 41818-41823, October 30, 1987.

2)         Persons with AIDS, HIV infection or increased risk of HIV infection are prohibited from donating blood, plasma, body organs, other tissues or sperm, except for the limited purposes of autologous transfusion, installation, transplantation or injection, or for medical research.  Individuals with increased risk of HIV infection include:

A)        Persons who have signs and symptoms suggestive of AIDS (e.g. a combination of two or more of the following:  unexpected weight loss of greater than 10% of body weight, chronic fever, chronic lymphadenopathy, night sweats or chronic diarrhea);

B)        Persons who have had sexual contact with HIV-infected persons;

C)        Males who have had sexual contact with a male anytime since 1977;

D)        Persons who have immigrated anytime since 1977 from countries where heterosexual activity is thought to play a major role in transmission of HIV infection, such as Central Africa and Haiti as recognized by the Centers for Disease Control and Prevention;

E)         Persons who are, or have been, present or past drug users by self-injection;

F)         Hemophiliacs; or

G)        Current or former sexual partners of any of the persons listed in this subsection (c)(2).

3)         Blood and plasma collection centers, and organ, tissue and sperm banks shall advise prospective donors that persons with AIDS, HIV infection or increased risk of HIV infection shall not donate blood, plasma, body organs, other tissues or sperm, except for autologous or medical research purposes.

4)         When a patient with AIDS or HIV infection or any infectious or communicable disease that could be transmitted through contact with the person's body or bodily fluids dies, the body shall be labeled "infectious hazard" or with an equivalent term to inform any funeral director, embalmer or other person having subsequent contact with the body, to take suitable precautions.

A)        If an equivalent term is used, it shall not include the words "AIDS", "Acquired Immunodeficiency Syndrome", "ARC", "AIDS related complex, "HIV", "Human Immunodeficiency Virus," or other terms synonymous with AIDS, ARC, or HIV.  The label shall be prominently displayed on and affixed to the outer wrapper or covering of the body if the body is covered or wrapped in any manner.

B)        When death occurs in a health care facility, the Administrator shall designate a staff member to assure responsibility for such labeling.  In all other cases, the attending physician or coroner who certifies the death shall assume responsibility for such labeling.  (Section 7 of the Department of Public Health Act [20 ILCS 2305/7])

5)         Providers of health care services to the following persons are encouraged to counsel the client or patient on the risks of HIV infection and offer testing for HIV infection, or refer the client or patient to an appropriate local public agency for this purpose:

A)        Persons diagnosed with an STD, or attending an STD clinic;

B)        Persons being treated for, or applying for treatment of drug addiction;

C)        Women attending family planning programs or contemplating pregnancy; and

D)        Persons with increased risk of HIV infection (See Section 693.140(c)(2)(A) through (G) of this Part.).

6)         When a child with AIDS or HIV infection attends school, the Guidelines for Management of Chronic Infectious Diseases in School Children should be observed.

d)         Special control measures for ophthalmia neonatorum

1)         It shall be the duty of any physician, midwife or nurse who attends or assists at the birth of a child, to instill or have instilled in each eye of the new born baby, as soon as possible and not later than one hour after birth, a one percent (1%) solution of silver nitrate or some other equally effective prophylactic for the prevention of ophthalmia neonatorum approved by the State Department of Public Health. (Section 3 of the Infant Eye Disease Act [410 ILCS 215/3])

2)         The Department approves 1% silver nitrate solution or ophthalmic ointment or drops containing tetracycline or erythromycin as a prophylactic for opthalmia neonatorum.

3)         It is the duty of all hospitals and places of childbirth to maintain records of cases of ophthalmia neonatorum pursuant to 77 Ill. Adm. Code 250.1830(i)(4)(B).

4)         If gonorrhea is suspected, antepartum treatment of the mother is recommended.

5)         The local health authority shall investigate the source of infection pursuant to Section 693.40(a) of this Part.

(Source:  Amended at 25 Ill. Reg. 3916, effective April 1, 2001)